LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -25.0% | 82 | -14.6% | 0.00% | -33.3% |
| Q1 2019 | $12,000 | -29.4% | 96 | -22.6% | 0.01% | -33.3% |
| Q4 2018 | $17,000 | -50.0% | 124 | 0.0% | 0.01% | -43.8% |
| Q3 2018 | $34,000 | +13.3% | 124 | -13.3% | 0.02% | +23.1% |
| Q2 2018 | $30,000 | -3.2% | 143 | -23.9% | 0.01% | -7.1% |
| Q1 2018 | $31,000 | +24.0% | 188 | +13.3% | 0.01% | +16.7% |
| Q4 2017 | $25,000 | +8.7% | 166 | -1.2% | 0.01% | 0.0% |
| Q3 2017 | $23,000 | +27.8% | 168 | +9.8% | 0.01% | +20.0% |
| Q2 2017 | $18,000 | +5.9% | 153 | 0.0% | 0.01% | +11.1% |
| Q1 2017 | $17,000 | +88.9% | 153 | +73.9% | 0.01% | +80.0% |
| Q4 2016 | $9,000 | – | 88 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |